If you are still having problems viewing this message, please click here for additional help.

Modern Pathology


Advanced Imaging with Proven Optics

Olympus is dedicated to your work, vision, and science. Through innovation and service, we seek to aide in your discoveries, advance your research, and inspire you to explore new possibilities. Our wide range of microscopes are built with the optical excellence and proven application expertise you can depend on. Your Science Matters™.

> Learn more about Olympus microscopes

Volume 31, Issue 4

In this issue
Inside the USCAP Journals
Original Articles
Letter to the Editor
Also new
Inaugural AACR International Meeting Advances in Malignant Lymphoma: Maximizing the Basic-Translational Interface for Clinical Application

Join the American Association for Cancer Research, June 22-26, 2018 in Boston, MA, for the first AACR biennial meeting on malignant lymphoma, which is being held in cooperation with the International Conference on Malignant Lymphoma (ICML).

For more information, click here 
Celebrating 30 years of Modern Pathology - 1988 to 2018

Thank you to the editors, board members, contributors, reviewers and readers, past and present for their invaluable contributions, and for bringing the journal to this milestone. 

Watch our anniversary video looking back at some Modern Pathology highlights >>> 

Inside the USCAP Journals

Inside the USCAP Journals


Modern Pathology 2018 31 :544 - 545; April 18, 2018; 10.1038/modpathol.2018.27


Abstract | Full Text

Original Articles

Frozen sections are unreliable for the diagnosis of necrotizing soft tissue infections

Isaac H Solomon, Rene Borscheid, Alvaro C Laga, Reza Askari & Scott R Granter

Modern Pathology 2017 31 :546 - 552; December 15, 2017; 10.1038/modpathol.2017.173


Abstract | Full Text

Expression of enhancer of zeste homolog 2 (EZH2) protein in histiocytic and dendritic cell neoplasms with evidence for p-ERK1/2-related, but not MYC- or p-STAT3-related cell signaling

Xuejun Tian, Jie Xu, Christopher Fletcher, Jason L Hornick & David M Dorfman

Modern Pathology 2018 31 :553 - 561; January 12, 2018; 10.1038/modpathol.2017.174


Abstract | Full Text

Will oncotype DX DCIS testing guide therapy? A single-institution correlation of oncotype DX DCIS results with histopathologic findings and clinical management decisions

Chieh-Yu Lin, Kelly Mooney, Winward Choy, Soo-Ryum Yang, Keegan Barry-Holson et al.

Modern Pathology 2017 31 :562 - 568; December 15, 2017; 10.1038/modpathol.2017.172


Abstract | Full Text

Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome

Cecilia C S Yeung, Scott McElhone, Xue Yan Chen, David Ng, Barry E Storer et al.

Modern Pathology 2017 31 :569 - 580; December 15, 2017; 10.1038/modpathol.2017.157


Abstract | Full Text

The histopathology of Erdheim–Chester disease: a comprehensive review of a molecularly characterized cohort

Neval Ozkaya, Marc K Rosenblum, Benjamin H Durham, Janine D Pichardo, Omar Abdel-Wahab et al.

Modern Pathology 2017 31 :581 - 597; December 01, 2017; 10.1038/modpathol.2017.160


Abstract | Full Text

Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study

Lauren E Rosen, Theodore Karrison, Vijayalakshmi Ananthanarayanan, Alexander J Gallan, Prasad S Adusumilli et al.

Modern Pathology 2018 31 :598 - 606; January 12, 2018; 10.1038/modpathol.2017.170


Abstract | Full Text

Clinical relevance and concordance of HER2 status in local and central testing—an analysis of 1581 HER2-positive breast carcinomas over 12 years

Berit M Pfitzner, Bianca Lederer, Judith Lindner, Christine Solbach, Knut Engels et al.

Modern Pathology 2017 31 :607 - 615; December 22, 2017; 10.1038/modpathol.2017.171


Abstract | Full Text

Tissue staining for THSD7A in glomeruli correlates with serum antibodies in primary membranous nephropathy: a clinicopathological study

Shree G Sharma & Christopher P Larsen

Modern Pathology 2017 31 :616 - 622; December 15, 2017; 10.1038/modpathol.2017.163


Abstract | Full Text

Concordance study of PD-L1 expression in primary and metastatic bladder carcinomas: comparison of four commonly used antibodies and RNA expression

Maria Tretiakova, Regan Fulton, Masha Kocherginsky, Thomas Long, Cigdem Ussakli et al.

Modern Pathology 2017 31 :623 - 632; December 22, 2017; 10.1038/modpathol.2017.188


Abstract | Full Text

Clinicopathologic and outcome study of sessile serrated adenomas/polyps with serrated versus intestinal dysplasia

Odise Cenaj, Joanna Gibson & Robert D Odze

Modern Pathology 2017 31 :633 - 642; December 22, 2017; 10.1038/modpathol.2017.169


Abstract | Full Text

Intramucosal lipomas of the colon implicate Cowden syndrome

Aybuke Caliskan, Wendy K Kohlmann, Kajsa E Affolter, Erinn Downs-Kelly, Priyanka Kanth et al.

Modern Pathology 2017 31 :643 - 651; December 01, 2017; 10.1038/modpathol.2017.161


Abstract | Full Text

Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging

Naveena Singh, Asma Faruqi, Friedrich Kommoss, W Glenn McCluggage, Giorgia Trevisan et al.

Modern Pathology 2017 31 :652 - 659; November 17, 2017; 10.1038/modpathol.2017.159


Abstract | Full Text

Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation

Benjamin Goode, Nancy M Joseph, Meredith Stevers, Jessica Van Ziffle, Courtney Onodera et al.

Modern Pathology 2017 31 :660 - 673; November 17, 2017; 10.1038/modpathol.2017.153


Abstract | Full Text

ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity

Natasha Lewis, Robert A Soslow, Deborah F Delair, Kay J Park, Rajmohan Murali et al.

Modern Pathology 2017 31 :674 - 684; December 01, 2017; 10.1038/modpathol.2017.162


Abstract | Full Text

Letter to the Editor

Expanding definitions of HER2 positivity

Steven Sorscher

Modern Pathology 2018 31 :685 - 685; April 18, 2018; 10.1038/modpathol.2017.141


Abstract | Full Text

Reply to Commentary on ‘HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features’

Rachel L Stewart, Evin H Gulbahce, Katherine B Geiersbach & Erinn Downs-Kelly

Modern Pathology 2018 31 :686 - 686; April 18, 2018; 10.1038/modpathol.2018.28


Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Modern Pathology. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature